Similar articles for PMID: 19567246

Year	Number of Results
1982	1
1983	1
1985	2
1991	1
1992	1
1993	1
1994	3
1995	1
1996	2
1999	1
2003	1
2004	1
2005	5
2006	6
2007	7
2008	8
2009	12
2010	5
2011	3
2012	7
2013	13
2014	9
2015	3
2016	4
2017	4
2018	8
2019	1
2020	2
2024	0

1

Safety, reactogenicity and immunogenicity of Francisella tularensis live vaccine strain in humans.

El Sahly HM, Atmar RL, Patel SM, Wells JM, Cate T, Ho M, Guo K, Pasetti MF, Lewis DE, Sztein MB, Keitel WA. El Sahly HM, et al. Vaccine. 2009 Aug 6;27(36):4905-11. doi: 10.1016/j.vaccine.2009.06.036. Epub 2009 Jun 28. Vaccine. 2009. PMID: 19567246 Free PMC article. Clinical Trial.

2

An improved Francisella tularensis live vaccine strain (LVS) is well tolerated and highly immunogenic when administered to rabbits in escalating doses using various immunization routes.

Pasetti MF, Cuberos L, Horn TL, Shearer JD, Matthews SJ, House RV, Sztein MB. Pasetti MF, et al. Vaccine. 2008 Mar 25;26(14):1773-85. doi: 10.1016/j.vaccine.2008.01.005. Epub 2008 Jan 29. Vaccine. 2008. PMID: 18308432 Free PMC article.

3

Tularemia vaccine: Safety, reactogenicity, "Take" skin reactions, and antibody responses following vaccination with a new lot of the Francisella tularensis live vaccine strain - A phase 2 randomized clinical Trial.

Mulligan MJ, Stapleton JT, Keitel WA, Frey SE, Chen WH, Rouphael N, Edupuganti S, Beck A, Winokur PL, El Sahly HM, Patel SM, Atmar RL, Graham I, Anderson E, El-Kamary SS, Pasetti MF, Sztein MB, Hill H, Goll JB; DMID 08-0006 Tularemia Vaccine Study Group. Mulligan MJ, et al. Vaccine. 2017 Aug 24;35(36):4730-4737. doi: 10.1016/j.vaccine.2017.07.024. Epub 2017 Jul 24. Vaccine. 2017. PMID: 28750854 Free PMC article. Clinical Trial.

4

Novel catanionic surfactant vesicle vaccines protect against Francisella tularensis LVS and confer significant partial protection against F. tularensis Schu S4 strain.

Richard K, Mann BJ, Stocker L, Barry EM, Qin A, Cole LE, Hurley MT, Ernst RK, Michalek SM, Stein DC, Deshong P, Vogel SN. Richard K, et al. Clin Vaccine Immunol. 2014 Feb;21(2):212-26. doi: 10.1128/CVI.00738-13. Epub 2013 Dec 18. Clin Vaccine Immunol. 2014. PMID: 24351755 Free PMC article.

5

Cell-mediated and humoral immune responses after vaccination of human volunteers with the live vaccine strain of Francisella tularensis.

Waag DM, McKee KT Jr, Sandstrom G, Pratt LL, Bolt CR, England MJ, Nelson GO, Williams JC. Waag DM, et al. Clin Diagn Lab Immunol. 1995 Mar;2(2):143-8. doi: 10.1128/cdli.2.2.143-148.1995. Clin Diagn Lab Immunol. 1995. PMID: 7697521 Free PMC article. Clinical Trial.

6

Monophosphoryl Lipid A Enhances Efficacy of a Francisella tularensis LVS-Catanionic Nanoparticle Subunit Vaccine against F. tularensis Schu S4 Challenge by Augmenting both Humoral and Cellular Immunity.

Richard K, Mann BJ, Qin A, Barry EM, Ernst RK, Vogel SN. Richard K, et al. Clin Vaccine Immunol. 2017 Mar 6;24(3):e00574-16. doi: 10.1128/CVI.00574-16. Print 2017 Mar. Clin Vaccine Immunol. 2017. PMID: 28077440 Free PMC article.

7

Oral live vaccine strain-induced protective immunity against pulmonary Francisella tularensis challenge is mediated by CD4+ T cells and antibodies, including immunoglobulin A.

Ray HJ, Cong Y, Murthy AK, Selby DM, Klose KE, Barker JR, Guentzel MN, Arulanandam BP. Ray HJ, et al. Clin Vaccine Immunol. 2009 Apr;16(4):444-52. doi: 10.1128/CVI.00405-08. Epub 2009 Feb 11. Clin Vaccine Immunol. 2009. PMID: 19211773 Free PMC article.

8

Inactivated Francisella tularensis live vaccine strain protects against respiratory tularemia by intranasal vaccination in an immunoglobulin A-dependent fashion.

Baron SD, Singh R, Metzger DW. Baron SD, et al. Infect Immun. 2007 May;75(5):2152-62. doi: 10.1128/IAI.01606-06. Epub 2007 Feb 12. Infect Immun. 2007. PMID: 17296747 Free PMC article.

9

Innate and adaptive immune responses to an intracellular bacterium, Francisella tularensis live vaccine strain.

Elkins KL, Cowley SC, Bosio CM. Elkins KL, et al. Microbes Infect. 2003 Feb;5(2):135-42. doi: 10.1016/s1286-4579(02)00084-9. Microbes Infect. 2003. PMID: 12650771 Free article. Review.

10

Aerosol-, but not intradermal-immunization with the live vaccine strain of Francisella tularensis protects mice against subsequent aerosol challenge with a highly virulent type A strain of the pathogen by an alphabeta T cell- and interferon gamma- dependent mechanism.

Wayne Conlan J, Shen H, Kuolee R, Zhao X, Chen W. Wayne Conlan J, et al. Vaccine. 2005 Mar 31;23(19):2477-85. doi: 10.1016/j.vaccine.2004.10.034. Vaccine. 2005. PMID: 15752834

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year